Latest news
Annual Report 2016
Oslo, Norway, April 25, 2017 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2016, including the complete 2016 Annual Accounts with notes. The report is attached below. PCI Biotech Holding ASA Annual Report 2016 For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Per Walday, […]
Presentation of fimaCHEM Phase I data in bile duct cancer at The International Liver Congress 2017
Oslo, Norway, April 21, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that a poster of the fimaCHEM technology will be presented at the International Liver Congress 2017 – the annual meeting of the European Association for the Study of the Liver (EASL). The event […]
PCI Biotech searching for Chief Medical Officer
Oslo, Norway 7 April 2017 – PCI Biotech searching for Chief Medical Officer We are looking for an experienced Chief Medical Officer (CMO) who will play a key role in the success of PCI Biotech’s clinical programmes and ensure that the global product portfolio strategy complies with medical, regulatory and legislative requirements. The CMO will […]